CRONOS GROUP INC. Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
CRONOS GROUP INC. (CRON) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of $12.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-06
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $12.60M, a 42.05% decline year-over-year.
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$2.23M, a 148.14% decline year-over-year.
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $17.09M.
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $2.32M, a 88.26% decline year-over-year.
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $45.79M.
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was -$46.30M.
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$53.01M.
- CRONOS GROUP INC. comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$219.35M.
| Period end | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12.60M 10-Q · filed 2026-08-06 | $10.37M 10-Q · filed 2026-08-06 | $27.46M derived: sum of 3 quarters · filed 2026-08-06 | $29.77M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$2.23M 10-Q · filed 2026-05-11 | $14.86M derived: sum of 2 quarters · filed 2026-05-11 | $17.17M derived: sum of 3 quarters · filed 2026-05-11 | $38.92M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $17.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.41M derived: sum of 2 quarters · filed 2026-02-26 | $41.15M derived: sum of 3 quarters · filed 2026-08-06 | $45.79M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $2.32M 10-Q · filed 2025-11-06 | $24.06M derived: sum of 2 quarters · filed 2026-08-06 | $28.70M 10-Q · filed 2025-11-06 | $6.44M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $21.75M 10-Q · filed 2026-08-06 | $26.39M 10-Q · filed 2026-08-06 | $4.12M derived: sum of 3 quarters · filed 2026-08-06 | $23.85M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $4.64M 10-Q · filed 2026-05-11 | -$17.63M derived: sum of 2 quarters · filed 2026-05-11 | $2.11M derived: sum of 3 quarters · filed 2026-05-11 | -$16.81M derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | -$22.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.54M derived: sum of 2 quarters · filed 2026-02-26 | -$21.45M derived: sum of 3 quarters · filed 2026-02-26 | -$46.30M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $19.73M 10-Q · filed 2025-11-06 | $813.00K derived: sum of 2 quarters · filed 2025-11-06 | -$24.03M 10-Q · filed 2025-11-06 | -$46.42M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$18.92M 10-Q · filed 2025-08-07 | -$43.76M 10-Q · filed 2025-08-07 | -$66.16M derived: sum of 3 quarters · filed 2026-02-26 | -$88.02M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$24.84M 10-Q · filed 2025-05-08 | -$47.24M derived: sum of 2 quarters · filed 2026-02-26 | -$69.10M derived: sum of 3 quarters · filed 2026-02-26 | -$61.02M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | -$22.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$44.25M derived: sum of 2 quarters · filed 2026-02-26 | -$36.17M derived: sum of 3 quarters · filed 2026-02-26 | -$53.01M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | -$21.86M 10-Q · filed 2024-11-12 | -$13.78M derived: sum of 2 quarters · filed 2024-11-12 | -$30.62M 10-Q · filed 2024-11-12 | -$91.34M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $8.08M 10-Q · filed 2024-08-08 | -$8.76M 10-Q · filed 2024-08-08 | -$69.48M derived: sum of 3 quarters · filed 2025-02-27 | -$166.94M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$16.84M 10-Q · filed 2024-05-09 | -$77.56M derived: sum of 2 quarters · filed 2025-02-27 | -$175.02M derived: sum of 3 quarters · filed 2025-02-27 | -$219.52M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$60.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$158.18M derived: sum of 2 quarters · filed 2025-02-27 | -$202.67M derived: sum of 3 quarters · filed 2025-02-27 | -$219.35M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$97.46M 10-Q · filed 2023-11-08 | -$141.96M derived: sum of 2 quarters · filed 2023-11-08 | -$158.63M 10-Q · filed 2023-11-08 | -$291.27M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$44.50M 10-Q · filed 2023-08-08 | -$61.17M 10-Q · filed 2023-08-08 | -$193.81M derived: sum of 3 quarters · filed 2024-02-29 | -$138.96M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$16.68M 10-Q · filed 2023-05-09 | -$149.31M derived: sum of 2 quarters · filed 2024-02-29 | -$94.46M derived: sum of 3 quarters · filed 2024-02-29 | -$260.35M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | -$132.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$77.79M derived: sum of 2 quarters · filed 2024-02-29 | -$243.67M derived: sum of 3 quarters · filed 2024-02-29 | -$389.01M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $54.85M 10-Q · filed 2022-11-07 | -$111.03M derived: sum of 2 quarters · filed 2022-11-07 | -$256.38M 10-Q · filed 2022-11-07 | -$317.48M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | -$165.88M 10-Q · filed 2022-08-09 | $70.25M 10-Q · filed 2021-08-06 | -$311.22M 10-Q · filed 2022-08-09 | -$75.10M 10-Q · filed 2021-08-06 | -$372.33M derived: sum of 3 quarters · filed 2023-02-28 | -$277.70M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$145.34M 10-Q · filed 2022-05-10 | -$206.45M derived: sum of 2 quarters · filed 2023-02-28 | -$111.82M derived: sum of 3 quarters · filed 2023-02-28 | -$167.65M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | -$61.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $33.52M derived: sum of 2 quarters · filed 2023-02-28 | -$22.31M derived: sum of 3 quarters · filed 2023-02-28 | -$60.32M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $94.63M 10-Q · filed 2022-02-18 | $38.80M derived: sum of 2 quarters · filed 2022-02-18 | $788.00K 10-Q · filed 2022-02-18 | $90.62M derived: sum of 4 quarters · filed 2022-02-18 | ||
| 2020-06-30 | -$55.83M 10-Q/A · filed 2022-02-18 | -$93.84M 10-Q/A · filed 2022-02-18 | -$4.01M derived: sum of 3 quarters · filed 2022-02-18 | $587.70M derived: sum of 4 quarters · filed 2022-02-18 | ||
| 2020-03-31 | -$38.01M 10-Q · filed 2021-05-07 | $51.82M derived: sum of 2 quarters · filed 2021-05-07 | $643.53M derived: sum of 3 quarters · filed 2021-05-07 | $847.36M derived: sum of 4 quarters · filed 2021-05-07 | ||
| 2019-12-31 | $89.83M 10-K/A · filed 2020-03-30 | $681.54M derived: sum of 2 quarters · filed 2020-11-05 | $885.37M derived: sum of 3 quarters · filed 2020-11-05 | $1.20B 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $591.71M 10-Q · filed 2020-11-05 | $795.54M derived: sum of 2 quarters · filed 2020-11-05 | $1.11B 10-Q · filed 2020-11-05 | $1.10B derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $203.84M 10-Q · filed 2020-08-06 | $521.72M 10-Q · filed 2020-08-06 | $503.52M derived: sum of 3 quarters · filed 2020-08-06 | $501.56M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $317.89M 10-Q · filed 2020-05-08 | $299.69M derived: sum of 2 quarters · filed 2020-05-08 | $297.72M derived: sum of 3 quarters · filed 2020-05-08 | $290.05M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | -$18.20M 10-K/A · filed 2020-03-30 | -$20.17M derived: sum of 2 quarters · filed 2020-03-30 | -$27.84M derived: sum of 3 quarters · filed 2020-03-30 | -$34.15M 10-K · filed 2021-02-26 | ||
| 2018-09-30 | -$1.97M 10-K/A · filed 2020-03-30 | -$9.64M derived: sum of 2 quarters · filed 2020-03-30 | -$15.95M derived: sum of 3 quarters · filed 2020-03-30 | |||
| 2018-06-30 | -$7.67M 10-K/A · filed 2020-03-30 | -$13.98M derived: sum of 2 quarters · filed 2020-03-30 | ||||
| 2018-03-31 | -$6.31M 10-K/A · filed 2020-03-30 | |||||
| 2017-12-31 | $1.38M 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |